Document:

EXHIBIT
10.1 

 

 

 

BIOAFFINITY
TECHNOLOGIES, INC.

 

2014
Equity Incentive Plan

 

Adopted
by the Board of Directors

on
March 26, 2014

 

 

 

    	 

     

    

 

Table
of contents

 

	 	 	PAGE
	1.	Purposes.	1
	2.	Definitions.	1
	3.	Administration.	4
	4.	Shares
    Subject to the Plan.	5
	5.	Eligibility.	5
	6.	Option
    Provisions.	6
	7.	RESTRICTED
    STOCK AWARDS.	9
	8.	Covenants
    of the Company.	9
	9.	Use
    of Proceeds from Stock.	10
	10.	Miscellaneous.	10
	11.	Adjustments
    upon Changes in Stock .	12
	12.	Amendment
    of the Plan and Stock Awards.	13
	13.	Termination
    or Suspension of the Plan.	13
	14.	Choice
    of Law.	14

 

    	 

     

    

 

bioAffinity
Technologies, Inc.

 

2014
Equity Incentive Plan

 

1.
Purposes.

 

(a)
Eligible Stock Award Recipients. The persons eligible to receive Stock Awards are the Employees, Directors and Consultants of the
Company and its Affiliates.

 

(b)
Available Stock Awards. The purpose of the Plan is to provide a means by which eligible recipients of Stock Awards may be given an
opportunity to benefit from increases in value of the Common Stock through the granting of the following Stock Awards: (i) Incentive
Stock Options, (ii) Nonstatutory Stock Options, and (iii) restricted stock awards.

 

(c)
General Purpose. The Company, by means of the Plan, seeks to retain the services of the group of persons eligible to receive Stock
Awards, to secure and retain the services of new members of this group and to provide incentives for such persons to exert maximum efforts
for the success of the Company and its Affiliates.

 

2.
Definitions.

 

“Affiliate”
means any parent corporation or subsidiary corporation of the Company, whether now or hereafter existing, as those terms are
defined in Sections 424(e) and (f), respectively, of the Code.

 

“Board”
means the Board of Directors of the Company.

 

“Cause”
means a determination by the Company that the Participant has committed an act or acts constituting any of the following: (i)
dishonesty, fraud, misconduct or negligence in connection with Company duties, (ii) unauthorized disclosure or use of the Company’s
confidential or proprietary information, (iii) misappropriation of a business opportunity of the Company, (iv) materially aiding a competitor
of Company; (v) a felony conviction; or (vi) failure or refusal to attend to the duties or obligations of the Participant’s position,
or to comply with the Company’s rules, policies or procedures.

 

“Change
in Control” means (i) the consummation of a merger or consolidation of the Company with or into another entity or any other
stock acquisition or corporate reorganization, if more than 50% of the combined voting power of the continuing or surviving entity’s
securities outstanding immediately after such merger, consolidation, stock acquisition or other reorganization is owned by persons who
were not shareholders of the Company immediately prior to such merger, consolidation, stock acquisition or other reorganization; or (ii)
the sale, transfer or other disposition of all or substantially all of the Company’s assets. A transaction shall not constitute
a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that
will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.

 

“Code”
means the Internal Revenue Code of 1986, as amended.

 

“Committee”
means a committee of two or more members of the Board appointed by the Board in accordance with subsection 3(c).

 

    	 	1	 

     

    

 

“Common
Stock” means the common stock of the Company.

 

“Company”
means bioAffinity Technologies, Inc., a Delaware corporation.

 

“Consultant”
means any natural person, including an advisor, (i) engaged by the Company or an Affiliate to render consulting or advisory services
and who is compensated for such services, including members of any advisory board constituted by the Company, or (ii) who is a member
of the Board of Directors of an Affiliate. However, the term “Consultant” shall not include either Directors who are not
compensated by the Company for their services as Directors or Directors who are merely paid a director’s fee by the Company for
their services as Directors.

 

“Continuous
Service” means, with respect to Employees, service with the Company or an Affiliate that is not interrupted or terminated.
With respect to Directors or Consultants, Continuous Service means service with the Company, or a Parent or Subsidiary of the Company,
whether as a Director or Consultant, that is not interrupted or terminated. The Board or the chief executive officer of the Company,
in that party’s sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave
of absence approved by that party, including sick leave, military leave or any other personal leave.

 

“Director”
means a member of the Board of Directors of the Company.

 

“Disability”
means the permanent and total disability of a person within the meaning of Section 22(e)(3) of the Code.

 

“Employee”
means any person employed by the Company or an Affiliate. Mere service as a Director or payment of a director’s fee by
the Company or an Affiliate shall not be sufficient to constitute “employment” by the Company or an Affiliate.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Fair
Market Value” means, as of any date, the value of the Common Stock determined in good faith by the Board.

 

“Incentive
Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the
Code and the regulations promulgated thereunder.

 

“Listing
Date” means the first date upon which any class of securities of the Company is listed on any securities exchange or quoted
on a nationally-recognized stock exchange or interdealer quotation system.

 

“Non-Employee
Director” means a Director who either (i) is not a current Employee or Officer of the Company or its parent or a subsidiary,
does not receive compensation (directly or indirectly) from the Company or its parent or a subsidiary for services rendered as a consultant
or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation
S-K), does not possess an interest in any other transaction as to which disclosure would be required under Item 404(a) of Regulation
S-K and is not engaged in a business relationship as to which disclosure would be required under Item 404(b) of Regulation S-K, or (ii)
is otherwise considered a “non-employee director” for purposes of Rule 16b-3.

 

    	 	2	 

     

    

 

“Nonstatutory
Stock Option” means an Option not intended to qualify as an Incentive Stock Option.

 

“Officer”
means (i) before the Listing Date, any person designated by the Company as an officer; and (ii) on and after the Listing Date,
a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated
thereunder.

 

“Option”
means an Incentive Stock Option or a Nonstatutory Stock Option granted pursuant to the Plan.

 

“Option
Agreement” means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an
individual Option grant. Each Option Agreement shall be subject to the terms and conditions of the Plan.

 

“Optionholder”
means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding
Option.

 

“Outside
Director” means a Director who either (i) is not a current employee of the Company or an “affiliated corporation”
(within the meaning of Treasury Regulations promulgated under Section 162(m) of the Code), is not a former employee of the Company or
an “affiliated corporation” receiving compensation for prior services (other than benefits under a tax qualified pension
plan), was not an officer of the Company or an “affiliated corporation” at any time and is not currently receiving direct
or indirect remuneration from the Company or an “affiliated corporation” for services in any capacity other than as a Director,
or (ii) is otherwise considered an “outside director” for purposes of Section 162(m) of the Code.

 

“Participant”
means a person to whom a Stock Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding
Stock Award.

 

“Plan”
means this 2014 Equity Incentive Plan, as amended from time to time.

 

“Regulation
S-K” means Regulation S-K promulgated pursuant to the Securities Act, as in effect from time to time.

 

“Rule
16b-3” means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Stock
Award” means any right granted under the Plan, including an Option and a restricted stock grant.

 

“Stock
Award Agreement” means a written agreement between the Company and a holder of a Stock Award evidencing the terms and conditions
of an individual Stock Award grant. Each Stock Award Agreement shall be subject to the terms and conditions of the Plan.

 

“Ten
Percent Shareholder” means a person who owns (or is deemed to own pursuant to Section 424(d) of the Code) stock comprising
more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any of its Affiliates.

 

    	 	3	 

     

    

 

3.
Administration.

 

(a)
Administration by Board. The Board shall administer the Plan unless and until the Board delegates administration to a Committee,
as provided in subsection 3(c). Whether or not the Board has delegated administration, the Board shall have the final power to determine
all questions of policy and expediency that may arise in the administration of the Plan.

 

(b)
Powers of Board. The Board (or the Committee) shall have the power, subject to, and within the limitations of, the express provisions
of the Plan:

 

(i)
To determine from time to time which of the persons eligible under the Plan shall be granted Stock Awards; when and how each Stock
Award shall be granted; what type or combination of types of Stock Award shall be granted; the provisions of each Stock Award granted
(which need not be identical), including the time or times when a person shall be permitted to receive Common Stock pursuant to a Stock
Award; and the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such person.

 

(ii)
To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and regulations for
its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any
Stock Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective.

 

(iii)
To amend the Plan or a Stock Award as provided in Section 12.

 

(iv)
Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests
of the Company that are not in conflict with the provisions of the Plan.

 

(c)
Delegation to Committee. The Board may delegate administration of the Plan to a Committee or Committees of two (2) or more members
of the Board, and the term “Committee” shall apply to any person or persons to whom such authority has been delegated. If
administration is delegated to such a Committee, the Committee shall have, in connection with the administration of the Plan, the powers
theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative powers the Committee
is authorized to exercise (and references in this Plan to the Board shall thereafter be deemed to be to the Committee or subcommittee,
as appropriate), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time
to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan.

 

(d)
Effect of Board’s Decision. All determinations, interpretations and constructions made by the Board in good faith shall not
be subject to review by any person and shall be final, binding and conclusive on all persons.

 

    	 	4	 

     

    

 

4.
Shares Subject to the Plan.

 

(a)
Share Reserve. The Common Stock that may be issued pursuant to Stock Awards hereunder shall not exceed in the aggregate the greater
of (i) 8,000,000 shares of Common Stock, or (ii) that number of shares equal to 20% of the total issued and outstanding shares of Common
Stock. The shares that may be issuable under incentive stock options shall be limited to the maximum number of shares reserved under
the Plan pursuant to this Section 4(a). All share numbers set forth in this Section 4(a) are subject to the provisions of Section 11
relating to adjustments upon changes in Common Stock.

 

(b)
Reversion of Shares to the Share Reserve. If any Stock Award granted under the Plan shall for any reason expire or otherwise terminate,
in whole or in part, without having been exercised in full, or if any shares of Common Stock issued to a Participant pursuant to a Stock
Award granted under the Plan are forfeited back to or repurchased by the Company, including, but not limited to, any repurchase or forfeiture
caused by the failure to meet a contingency or condition required for the vesting or exercise of such shares, then the shares of Common
Stock not acquired under such Stock Award shall become available for issuance under the Plan. The number of shares of Common Stock underlying
a Stock Award not issued as a result of payment of the Option exercise price and/or payment of any taxes arising upon exercise of the
Option by withholding shares of Common Stock which otherwise would be acquired on exercise or issued upon such payout shall again be
available for issuance under the Plan.

 

(c)
Source of Shares. The shares of Common Stock subject to the Plan may be authorized but unissued shares or reacquired shares.

 

5.
Eligibility.

 

(a)
Eligibility for Specific Stock Awards. Incentive Stock Options may be granted only to Employees. Stock Awards other than Incentive
Stock Options may be granted to Employees, Directors and Consultants.

 

(b)
Ten Percent Shareholders. A Ten Percent Shareholder shall not be granted an Incentive Stock Option unless the exercise price of such
Option is at least one hundred ten percent (110%) of the Fair Market Value of the Common Stock at the date of grant and the Option is
not exercisable after the expiration of five (5) years from the date of grant.

 

(c)
Consultants. Prior to the Company becoming subject to the reporting requirements of section 13 or 15(d) of the Exchange Act, a Consultant
shall not be eligible for the grant of a Stock Award if, at the time of grant, either the offer or the sale of the Company’s securities
to such Consultant would not be exempt under Rule 701 of the Securities Act (“Rule 701”) because of the nature of the services
that the Consultant is providing to the Company, or because the Consultant is not a natural person, or as otherwise provided by Rule
701, unless the Company determines that such grant need not comply with the requirements of Rule 701 and will satisfy another exemption
under the Securities Act as well as comply with the securities laws of all other relevant jurisdictions. After the Company has become
subject to the reporting requirements of section 13 or 15(d) of the Exchange Act, a Consultant shall not be eligible for the grant of
a Stock Award if, at the time of grant, a Form S-8 Registration Statement under the Securities Act (“Form S-8”) is not available
to register either the offer or the sale of the Company’s securities to such Consultant because of the nature of the services that
the Consultant is providing to the Company, or because the Consultant is not a natural person, or as otherwise provided by the rules
governing the use of Form S-8, unless the Company determines both (i) that such grant (A) shall be registered in another manner under
the Securities Act (e.g., on a Form S-3 Registration Statement) or (B) does not require registration under the Securities Act in order
to comply with the requirements of the Securities Act, if applicable, and (ii) that such grant complies with the securities laws of all
other relevant jurisdictions.

 

    	 	5	 

     

    

 

(d)
Foreign Participants. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries
in which the Company and its subsidiaries operate or have Employees, Directors or Consultants, the Board, in its sole discretion, shall
have the power and authority to: (i) determine which subsidiaries shall be covered by the Plan; (ii) determine which Employees, Directors
or Consultants outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of any Stock
Award granted to Employees, Directors or Consultants outside the United States to comply with applicable foreign laws; (iv) establish
subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable (any
such subplans and/or modifications shall be attached to this subplan as appendices); provided, however, that no such subplans and/or
modifications shall increase the number of shares reserved for the Plan as set forth in Section 4 of the Plan; and (v) take any action,
before or after a Stock Award is made, that it deems advisable to obtain approval or comply with any applicable foreign laws.

 

6.
Option Provisions.

 

Each
Option shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. All Options shall be separately
designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate
or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. The provisions of separate Options
need not be identical, but each Option shall include (through incorporation of provisions hereof by reference in the Option or otherwise)
the substance of each of the following provisions:

 

(a)
Term. Subject to the provisions of subsection 5(b) regarding Ten Percent Shareholders, no Incentive Stock Option shall be exercisable
after the expiration of ten (10) years from the date it was granted.

 

(b)
Exercise Price of an Incentive Stock Option. Subject to the provisions of subsection 5(b) regarding Ten Percent Shareholders, the
exercise price of each Incentive Stock Option shall be not less than one hundred percent (100%) of the Fair Market Value of the Common
Stock subject to the Incentive Stock Option on the date the Option is granted. Notwithstanding the foregoing, an Incentive Stock Option
may be granted with an exercise price lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption
or substitution for another option in a manner satisfying the provisions of Section 424(a) of the Code.

 

(c)
Exercise Price of a Nonstatutory Stock Option. The exercise price of Nonstatutory Stock Options shall be determined by the Board.
However, the exercise price of each Nonstatutory Stock Option that is intended to qualify as performance-based compensation within the
meaning of the Treasury Regulations promulgated under Section 162(m) of the Code shall be not less than one hundred percent (100%) of
the Fair Market Value of the Common Stock subject to the Option on the date the Option is granted.

 

    	 	6	 

     

    

 

(d)
Consideration. The purchase price of Common Stock acquired pursuant to an Option shall be paid, to the extent permitted by applicable
statutes and regulations, either (i) in cash at the time the Option is exercised, or (ii) at the discretion of the Board at the time
of the grant of the Option (or subsequently in the case of a Nonstatutory Stock Option) (A) by delivery to the Company of other shares
of Common Stock, (B) according to a deferred payment or other similar arrangement with the Optionholder, (C) pursuant to a cashless exercise
program implemented by the Company in connection with the Plan, or (D) in any other form of legal consideration that may be acceptable
to the Board.

 

In
the case of any deferred payment arrangement, interest shall be compounded at least annually and shall be charged at the minimum rate
of interest necessary to avoid the treatment as interest, under any applicable provisions of the Code, of any amounts other than amounts
stated to be interest under the deferred payment arrangement.

 

(e)
Transferability of an Incentive Stock Option. An Incentive Stock Option shall not be transferable except by will or by the laws of
descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the
foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third
party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option.

 

(f)
Transferability of a Nonstatutory Stock Option. A Nonstatutory Stock Option shall be transferable only to the extent provided in
the Option Agreement (subject to applicable securities laws). Notwithstanding the foregoing, the Optionholder may, by delivering written
notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder,
shall thereafter be entitled to exercise the Option.

 

(g)
Vesting Generally. The total number of shares of Common Stock subject to an Option may, but need not, vest and therefore become exercisable
in periodic installments that may, but need not, be equal. The Option may be subject to such other terms and conditions on the time or
times when it may be exercised (which may be based on performance or other criteria) as the Board may deem appropriate. The vesting provisions
of individual Options may vary. The provisions of this subsection 6(g) are subject to any Option provisions governing the minimum number
of shares of Common Stock as to which an Option may be exercised.

 

(h)
Termination of Continuous Service. In the event an Optionholder’s Continuous Service terminates (other than upon the Optionholder’s
death or Disability), the Optionholder may exercise his or her Option up to the date of termination unless a longer period for exercise
is provided in the Optionholder’s Option Agreement (but only to the extent that the Optionholder was entitled to exercise such
Option as of the date of termination according to the terms of the Option Agreement), but in no event after the expiration of the term
of the Option as set forth in the Option Agreement. If the Optionholder does not exercise his or her Option within the time specified
in the Option Agreement, the Option shall terminate.

 

(i)
Extension of Termination Date. Except with respect to Incentive Stock Options, an Optionholder’s Option Agreement may also
provide that if the exercise of the Option following the termination of the Optionholder’s Continuous Service (other than upon
the Optionholder’s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would
violate the registration requirements under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration
of the term of the Option set forth in subsection 6(a), or (ii) the expiration of a period of one (1) month after the termination of
the Optionholder’s Continuous Service during which the exercise of the Option would not be in violation of such registration requirements.

 

    	 	7	 

     

    

 

(j)
Disability of Optionholder. In the event that an Optionholder’s Continuous Service terminates as a result of the Optionholder’s
Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option
as of the date of termination), but only within such period of time ending on the earlier of (i) the date six (6) months following such
termination (or, except with respect to Incentive Stock Options, such longer or shorter period specified in the Option Agreement) or
(ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not
exercise his or her Option within the time specified herein, the Option shall terminate.

 

(k)
Death of Optionholder. In the event an Optionholder’s Continuous Service terminates as a result of the Optionholder’s
death, then the Option may be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death)
by the Optionholder’s estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person
designated to exercise the Option upon the Optionholder’s death pursuant to subsection 6(e) or 6(f), but only within the period
ending on the earlier of (A) the date six (6) months following the date of death (or, except with respect to an Incentive Stock
Option, such longer or shorter period specified in the Option Agreement) or (B) the expiration of the term of such Option as set forth
in the Option Agreement. If, after death, the Option is not exercised within the time specified herein, the Option shall terminate.

 

(l)
Early Exercise. The Option may, but need not, include a provision whereby the Optionholder may elect at any time before the Optionholder’s
Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock subject to the Option prior
to the full vesting of the Option. The early purchase of any unvested shares of Common Stock will be pursuant to an early exercise provision
in the Option Agreement which may provide for a repurchase option and/or a right of first refusal in favor of the Company and other restrictions
the Board determines to be appropriate. Any repurchase option so provided for will be subject to the repurchase provisions set forth
in Section 11(h) herein.

 

(m)
Right of Repurchase. Subject to the repurchase provisions in Section 11(h), the Option may, but need not, include a provision whereby
the Company may elect to repurchase all or any part of the vested shares of Common Stock acquired by the Optionholder pursuant to the
exercise of the Option.

 

(n)
Right of First Refusal. The Option may, but need not, include a provision whereby the Company may elect, prior to the Listing Date,
to exercise a right of first refusal following receipt of notice from the Optionholder of the intent to transfer all or any part of the
shares of Common Stock received upon the exercise of the Option.

 

    	 	8	 

     

    

 

7.
RESTRICTED STOCK AWARDS.

 

Grants
of restricted stock shall be pursuant to a Stock Award Agreement, which shall be in such form and shall contain such terms and conditions
as the Board shall deem appropriate. The terms and conditions of each restricted stock grant shall include (through incorporation of
provisions hereof by reference in the Stock Award Agreement or otherwise) the substance of each of the following provisions:

 

(a)
Designation. Restricted stock may be granted under the Plan and may include a dividend equivalent right as permitted by Section 11(a).
After the Board determines that it will grant restricted stock, it will advise the Participant, by means of a Stock Award Agreement,
of the terms, conditions and restrictions, including vesting, if any, related to the offer, including the number of shares of Common
Stock that the Participant shall be entitled to receive or purchase, the price to be paid, if any, and, if applicable, the time within
which the Participant must accept the offer. The offer shall be accepted by execution of a Stock Award Agreement or as otherwise directed
by the Board. The term of each award of restricted stock shall be at the discretion of the Board.

 

(b)
Restrictions. Subject to Section 3(b)(iii), the Board may impose such conditions or restrictions on the restricted stock granted
pursuant to the Plan as it may determine advisable, including the achievement of specific performance goals, a share repurchase option
in favor of the Company (subject to the repurchase provisions set forth in Section 11(h)), time based restrictions on vesting, or others.
If the Board established performance goals, the Board shall determine whether a Participant has satisfied the performance goals.

 

(c)
Performance Criteria. Restricted stock granted pursuant to the Plan that are intended to qualify as “performance based compensation”
under Section 162(m) of the Code shall be subject to the attainment of performance goals relating to the Performance Criteria selected
by the Board and specified at the time such restricted stock are granted. For purposes of this Plan, “Performance Criteria”
means one or more of the following (as selected by the Board and as such list may be amended or supplemented from time to time by the
Plan Administrator): (1) cash flow; (2) earnings per share; (3) earnings before interest, taxes, and amortization; (4) return on equity;
(5) total shareholder return; (6) share price performance; (7) return on capital; (8) return on assets or net assets; (9) revenue; (10)
revenue growth; (11) earnings growth; (12) operating income; (13) operating profit; (14) profit margin; (15) return on operating revenue;
(16) return on invested capital; (17) market price; (18) brand recognition; (19) customer satisfaction; (20) operating efficiency; or
(21) productivity. Any of these Performance Criteria may be used to measure the performance of the Company as a whole or any business
unit or division of the Company.

 

(d)
Transferability. Restricted stock shall be transferable by the Participant only upon such terms and conditions as are set forth in
the Stock Award Agreement, as the Board shall determine in its discretion.

 

8.
Covenants of the Company.

 

(a)
Availability of Shares. During the terms of the Stock Awards, the Company shall keep available at all times the number of shares
of Common Stock required to satisfy such Stock Awards.

 

(b)
Securities Law Compliance. The Company shall seek to obtain from each regulatory commission or agency having jurisdiction over the
Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock
Awards; provided, however, that this undertaking shall not require the Company to register under the Securities Act or qualify under
any state securities laws the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after
reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the
Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability
for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained.

 

    	 	9	 

     

    

 

9.
Use of Proceeds from Stock.

 

Proceeds
from the sale of Common Stock pursuant to Stock Awards shall constitute general funds of the Company.

 

10.
Miscellaneous.

 

(a)
Acceleration of Exercisability and Vesting. The Board shall have the power to accelerate the time at which a Stock Award may first
be exercised or the time during which a Stock Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions
in the Stock Award stating the time at which it may first be exercised or the time during which it will vest.

 

(b)
Shareholder Rights. No Participant shall be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any shares of Common Stock subject to a Stock Award unless and until such Participant has satisfied all requirements for exercise of
the Stock Award pursuant to its terms and the Company has issued the shares.

 

(c)
No Employment or other Service Rights. Nothing in the Plan or any instrument executed or Stock Award granted pursuant thereto shall
confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock
Award was granted or shall affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without
notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant’s agreement with the
Company or an Affiliate, or (iii) the service of a Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable
provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.

 

(d)
Incentive Stock Option $100,000 Limitation. To the extent that the aggregate Fair Market Value (determined at the time of grant)
of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar
year (under all plans of the Company and its Affiliates) exceeds one hundred thousand dollars ($100,000), the Options or portions thereof
which exceed such limit (according to the order in which they were granted) shall be treated as Nonstatutory Stock Options.

 

    	 	10	 

     

    

 

(e)
Investment Assurances. The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Stock
Award (i) to give written assurances satisfactory to the Company as to the Participant’s knowledge and experience in financial
and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced
in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the
merits and risks of exercising the Stock Award, and (ii) to give written assurances satisfactory to the Company stating that the Participant
is acquiring Common Stock subject to the Stock Award for the Participant’s own account and not with any present intention of selling
or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, shall
be inoperative if (1) the issuance of the shares of Common Stock upon the exercise or acquisition of Common Stock under the Stock Award
has been registered under a then currently effective registration statement under the Securities Act, or (2) as to any particular requirement,
a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable
securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as
such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends
restricting the transfer of the Common Stock.

 

(f)
Withholding Obligations. To the extent provided by the terms of a Stock Award Agreement, the Participant may satisfy any federal,
state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under a Stock Award by any of the following
means (in addition to the Company’s right to withhold from any compensation paid to the Participant by the Company) or by a combination
of such means: (i) tendering a cash payment, (ii) authorizing the Company to withhold shares of Common Stock from the shares of Common
Stock otherwise issuable to the Participant as a result of the exercise or acquisition of Common Stock under the Stock Award, provided,
however, that no shares of Common Stock are withheld with a value exceeding the minimum amount of tax required to be withheld by law,
or (iii) delivering to the Company owned and unencumbered shares of Common Stock.

 

(g)
Repurchase Provisions. The Company shall exercise any repurchase option specified in a Stock Award by giving the holder of the Stock
Award written notice of intent to exercise the repurchase option. Payment may be cash, cancellation of indebtedness for the Common Stock
or a promissory note as more specifically provided in the Stock Award Agreement. Notwithstanding anything herein to the contrary, any
right of the Company to repurchase shares of Common Stock hereunder shall expire on the Listing Date. The terms of any repurchase option
shall be specified in the Stock Award Agreement and may be either at Fair Market Value at the time of repurchase or at the original purchase
price. Unless otherwise determined by the Board and provided in the Stock award, the repurchase option will be upon the following terms:

 

(i)
Fair Market Value. To the extent the Company has a repurchase option, subject to Section 10(g)(ii) herein, the Company will have
the right to repurchase the shares of Common Stock upon termination of Continuous Service at not less than the Fair Market Value, and
the Company’s option must be exercised by the Company by the later of (i) ninety (90) days after termination of Continuous Service,
or (ii) such longer period as may be agreed to by the Company and the Participant (for example, for purposes of satisfying the requirements
of Section 1202(c)(3) of the Code regarding “qualified small business stock”).

 

(ii)
Original Purchase Price. To the extent the Company has a repurchase option, the Company will have the right to repurchase shares
of Common Stock at the lesser of the Fair Market Value or the original purchase price if the Participant’s Continuous Service is
terminated for Cause. In such case the repurchase option must be exercised by the Company within sixty (60) days of termination of Continuous
Service or such longer period as may be agreed to by the Company and the Participant (for example, for purposes of satisfying the requirements
of Section 1202(c)(3) of the Code regarding “qualified small business stock”).

 

    	 	11	 

     

    

 

(h)
Golden Parachute Taxes. In the event that any amounts paid or deemed paid to a Participant under the Plan are deemed to constitute
“excess parachute payments” as defined in Section 280G of the Code (taking into account any other payments made under the
Plan and any other compensation paid or deemed paid to a Participant), or if any Participant is deemed to receive an “excess parachute
payment” by reason of his or her vesting of Options pursuant to Section 11(c) herein, the amount of such payments or deemed payments
shall be reduced (or, alternatively the provisions of Section 11(c) shall not act to vest options to such Participant), so that no such
payments or deemed payments shall constitute excess parachute payments. The determination of whether a payment or deemed payment constitutes
an excess parachute payment shall be in the sole discretion of the Board.

 

(i)
Plan Unfunded. The Plan shall be unfunded. Except for the Board’s reservation of a sufficient number of authorized shares to
the extent required by law to meet the requirements of the Plan, the Company shall not be required to establish any special or separate
fund or to make any other segregation of assets to assure payment of any Stock Award under the Plan.

 

11.
Adjustments upon Changes in Stock .

 

(a)
Capitalization Adjustments. In the event that any dividend or other distribution (whether in the form of cash, shares of the Common
Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation,
split-up, spin-off, combination, repurchase, exchange of Common Stock or other securities of the Company, or other change in the corporate
structure of the Company affecting the Common Stock occurs, the Board, in order to prevent diminution or enlargement of the benefits
or potential benefits intended to be made available under the Plan, may, in its sole discretion and without need of any further approval
of the shareholders or the holder of a Stock Award, (i) adjust the number and class of Common Stock that may be delivered under the Plan
and/or the number, class, and price of Common Stock covered by each outstanding Stock Award and (ii) determine that all references in
this Plan to specific share numbers be appropriately adjusted. In lieu of the payment of a dividend, the Board in its discretion may
provide holders of restricted stock a dividend equivalent right, in the form of additional shares of Common Stock, with respect to the
unvested shares of Common Stock the Participant shall be entitled to receive or purchase.

 

(b)
Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Board will notify each Participant
as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised,
a Stock Award will terminate immediately prior to the consummation of such proposed action.

 

    	 	12	 

     

    

 

(c)
Change in Control. 

 

(i)
A Stock Award may provide for accelerated vesting of all or any fraction of the unvested portion of a Stock Award in the event of
a Change in Control.

 

(ii)
In the event of Change in Control, then, to the extent permitted by applicable law: (1) any surviving corporation may assume any
Stock Awards outstanding under the Plan or may substitute similar stock awards (including an award to acquire the same consideration
paid to the shareholders in the transaction described in this Section 11(c)) for those outstanding under the Plan, or (2) in the event
any surviving corporation does not assume or continue such Stock Awards, or substitute similar stock awards for those outstanding under
the Plan in accordance with the preceding clause, then the time during which such Stock Awards may be exercised automatically will be
accelerated and become fully vested and exercisable immediately prior to the consummation of such transaction, and the Stock Awards shall
automatically terminate upon consummation of such transaction if not exercised prior to such event.

 

(d)
No Limitations. The grant of Stock Awards will in no way affect the Company’s right to adjust, reclassify, reorganize or otherwise
change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business
or assets.

 

12.
Amendment of the Plan and Stock Awards.

 

(a)
Amendment of Plan. The Board at any time, and from time to time, may amend the Plan. However, except as provided in Section 11 relating
to adjustments upon changes in Common Stock, no amendment shall be effective unless approved by the shareholders of the Company to the
extent shareholder approval is necessary to satisfy the applicable requirements of Section 422 or 162(m) of the Code and the Treasury
Regulations thereunder, Rule 16b-3 or any Nasdaq or securities exchange listing requirements.

 

(b)
Contemplated Amendments. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary
or advisable to provide eligible Employees with the maximum benefits provided or to be provided under the provisions of the Code and
the regulations promulgated thereunder relating to Incentive Stock Options and/or to bring the Plan and/or Incentive Stock Options granted
under it into compliance therewith.

 

(c)
No Impairment of Rights. Rights under any Stock Award granted before amendment of the Plan shall not be impaired by any amendment
of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing.

 

(d)
Amendment of Stock Awards. The Board at any time, and from time to time, may amend the terms of any one or more Stock Awards; provided,
however, that the rights under any Stock Award shall not be impaired by any such amendment unless the Participant consents thereto in
writing.

 

13.
Termination or Suspension of the Plan.

 

(a)
Plan Term. The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate on the day
before the tenth (10th) anniversary of the date the Plan is adopted by the Board or approved by the shareholders of the Company, whichever
is later. No Stock Awards may be granted under the Plan while the Plan is suspended or after it is terminated.

 

(b)
No Impairment of Rights. Suspension or termination of the Plan shall not impair rights and obligations under any Stock Award granted
while the Plan is in effect except with the written consent of the Participant.

 

14.
Choice of Law.

 

The
law of the State of Delaware shall govern all questions concerning the construction, validity and interpretation of this Plan, without
regard to such state’s conflict of laws rules.

 

    	 	13EXHIBIT
10.10

 

NOTE
PURCHASE AGREEMENT

 

This
NOTE PURCHASE AGREEMENT (this “Agreement”) is dated as of [DATE] and is made by and between bioAffinity Technologies
Inc., a Delaware corporation (the “Company”), and the investors named on the signature pages hereto (the “Investors”).

 

WHEREAS,
the Company has offered to certain accredited investors (as defined in Regulation D under the Securities Act of 1933, as amended)
up to $3,500,000 aggregate Principal Balance (which may be increased by the Company) of the Company’s 6% Notes due May 31, 2022
(the “Notes”) pursuant to a Confidential Private Placement Memorandum dated September 8, 2021 (the “PPM”);

 

WHEREAS,
each Investor has agreed pursuant to such Principal Balance of Notes set forth therein in accordance with the terms, subject to the
conditions, and in reliance on, the recitals, representations, warranties, covenants and agreements set forth herein.

 

NOW
THEREFORE, in consideration of the mutual covenants, conditions and agreements herein contained, the receipt and sufficiency of which
is hereby acknowledged, the parties hereto hereby agree as follows:

 

1.
Purchase and Sale of Notes. Subject to the terms and conditions set forth in this Section 1 and elsewhere in this Agreement, each
Investor has agreed to purchase from the Company, and the Company has agreed to sell to such Investor, at the Closing (as defined below)
the Principal Balance of Notes set forth on the Investor’s signature page. In addition to a Note, each Investor shall receive a
warrant (a “Warrant”) to purchase one share for each Conversion Share (as defined in the Note) based on the Principal Balance
of the Investor’s Note. Warrants shall have an exercise price equal to the Company’s initial public offering price (“IPO”)
or $0.75 per share if the Company does not complete its IPO by the Maturity Date as described in the Note.

 

2.
Closing; Deliveries. Subject to the satisfaction of the initial closing conditions (as set forth below), the initial closing (the
“Initial Closing”) of the purchase and sale of the Notes shall take place on the date hereof. At one or more subsequent
closings (each, a “Subsequent Closing,” and together with the Initial Closing, a “Closing”), the
Company may sell additional Notes to additional Investors.

 

At
each Closing, (i) each Investor who shall purchase Notes hereunder shall deliver or shall have previously delivered to the Company cash,
wire transfer or a certified check in an amount equal to 100% of the principal amount subscribed for by such Investor, together with
an executed signature page to this Agreement, and (ii) the Company shall issue and deliver to each Investor an executed Note in the Principal
Balance purchased by such Investor in substantially the form set forth at Exhibit A hereto and a Warrant in substantially the
form set forth at Exhibit B hereto. Each Closing shall take place at the principal executive offices of the Company or at such
other place or time as the Company may specify.

 

    	 

     

    

 

3.
Representations, Warranties and Covenants of Company. The Company represents and warrants to the Investors that as of the date
hereof:

 

a.
Corporate Existence and Power. (i) The Company is a corporation, duly organized, validly existing and in good standing under the
laws of the state of Delaware; (ii) the Company has the power and authority to conduct its business in the manner in which it is currently
being conducted; and (iii) the Company has the power and authority to execute, deliver and perform this Agreement, the Notes and the
Warrants (collectively, the “Transaction Documents”) and to sell and issue the Notes and Warrants hereunder.

 

b.
Valid and Binding Agreement. The execution, delivery and performance of each Transaction Document have been duly authorized by
all requisite action of the Company, and each Transaction Document constitutes a valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms. The execution, delivery and performance of this Agreement and the other Transaction
Documents by the Company does not and, to the knowledge of the Company, will not: (i) conflict with, or violate any provision of, statute,
law, rule, regulation, order, judgment, injunction, decree or award of any arbitrator or governmental authority having applicability
to the Company or its business, assets, or properties, or any provision of its certificate of incorporation, bylaws or similar governing
instruments or (ii) conflict with, violate, or result in any breach of, or constitute a default under, any agreement or instrument to
which the Company is now a party or by which the Company or any of its properties or assets may be bound or affected.

 

c.
Financial Condition. The PPM accurately describes in the Company’s business, properties and financial condition and there
is no material misstatements in the PPM.

 

4.
Representations and Warranties of the Investors.

 

a.
Purchase Entirely for Own Account. The Investor acknowledges that this Note is made with the Investor in reliance upon the Investor’s
representation to the Company, which the Investor hereby confirms by executing this Note, that this Note, the Warrant, the Conversion
Shares, and any Common Stock issuable upon exercise of the Warrant (collectively, the “Securities”) will be acquired for
investment for the Investor’s own account, not as a nominee or agent (unless otherwise specified on the Investor’s signature
page hereto), and not with a view to the resale or distribution of any part thereof, and that the Investor has no present intention of
selling, granting any participation in, or otherwise distributing the same. By executing this Note, the Investor further represents that
the Investor does not have any contract, undertaking, agreement or arrangement with any person to sell, transfer or grant participations
to such person or to any third person, with respect to the Securities. If other than an individual, the Investor also represents it has
not been organized solely for the purpose of acquiring the Securities.

 

b.
Disclosure of Information; Non-Reliance. The Investor acknowledges that it has received all the information it considers necessary
or appropriate to enable it to make an informed decision concerning an investment in the Securities. The Investor further represents
that it has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering
of the Securities. The Investor confirms that the Company has not given any guarantee or representation as to the potential success,
return, effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment in the Securities. In
deciding to purchase the Securities, the Investor is not relying on the advice or recommendations of the Company and has made its own
independent decision that the investment in the Securities is suitable and appropriate for the Investor. The Investor understands that
no federal or state agency has passed upon the merits or risks of an investment in the Securities or made any finding or determination
concerning the fairness or advisability of this investment.

 

    	 

     

    

 

c.
Investment Experience. The Investor is an investor in securities of companies in the development stage and acknowledges that it
is able to fend for itself, can bear the economic risk of its investment and has such knowledge and experience in financial or business
matters that it is capable of evaluating the merits and risks of the investment in the Securities.

 

d.
Accredited Investor. The Investor is an “accredited investor” within the meaning of Regulation D promulgated under
the Securities Act. The Investor agrees to furnish any additional information requested by the Company or any of its affiliates to assure
compliance with applicable U.S. federal and state securities laws in connection with the purchase and sale of the Securities.

 

e.
Restricted Securities. The Investor understands that the Securities have not been, and will not be, registered under the Securities
Act or state securities laws, by reason of specific exemptions from the registration provisions thereof which depend upon, among other
things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations as expressed herein. The
Investor understands that the Securities are “restricted securities” under U.S. federal and applicable state securities laws
and that, pursuant to these laws, the Investor must hold the Securities indefinitely unless they are registered with the Securities and
Exchange Commission and registered or qualified by state authorities, or an exemption from such registration and qualification requirements
is available. The Investor acknowledges that the Company has no obligation to register or qualify the Securities for resale and further
acknowledges that, if an exemption from registration or qualification is available, it may be conditioned on various requirements including,
but not limited to, the time and manner of sale, the holding period for the Securities, and on requirements relating to the Company which
are outside of the Investor’s control, and which the Company is under no obligation, and may not be able, to satisfy.

 

f.
No Public Market. The Investor understands that no public market now exists for the Securities and that the Company has made no
assurances that a public market will ever exist for the Securities.

 

g.
No General Solicitation. The Investor, and its officers, directors, employees, agents, stockholders or partners have not either
directly or indirectly, including through a broker or finder solicited offers for or offered or sold the Securities by means of any form
of general solicitation or general advertising within the meaning of Rule 502 of Regulation D under the Securities Act or in any manner
involving a public offering within the meaning of Section 4(a)(2) of the Securities Act. The Investor acknowledges that neither the Company
nor any other person offered to sell the Securities to it by means of any form of general solicitation or advertising within the meaning
of Rule 502 of Regulation D under the Securities Act or in any manner involving a public offering within the meaning of Section 4(a)(2)
of the Securities Act.

 

    	 

     

    

 

5.
Limitations on Disposition. Without in any way limiting the representations set

 

forth
above, each Investor agrees not to make any disposition of all or any portion of the applicable Notes unless and until (i) there is then
in effect an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”),
covering such proposed disposition and such disposition is made in accordance with such registration statement; or (ii) an exemption
to registration under the Securities Act and applicable state securities laws is available. Each Investor further understands and agrees
that, until so registered or transferred pursuant to the provisions of Rule 144 under the Securities Act, the Notes, whether upon initial
issuance or upon any transfer thereof, shall bear a legend, prominently stamped or printed thereon, reading substantially as follows:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED, AND THE ISSUER HEREOF DOES NOT INTEND TO REGISTER THIS SECURITY, UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”) OR THE SECURITIES OR BLUE SKY LAWS OF ANY STATE AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED
OR SOLD EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND APPLICABLE STATE SECURITIES LAWS AND, IF REQUESTED BY THE ISSUER HEREOF, UPON DELIVERY TO THE ISSUER HEREOF OF AN OPINION OF COUNSEL
(SATISFACTORY TO THE ISSUER HEREOF) TO THE EFFECT THAT SUCH TRANSFER IS EXEMPT FROM REGISTRATION UNDER (OR OTHERWISE IN COMPLIANCE WITH)
THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAW.

 

THE
ISSUER OF THIS SECURITY IS NOT OBLIGATED TO RECOGNIZE ANY SALE OR OTHER TRANSFER OF THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN MADE
OTHER THAN IN ACCORDANCE WITH THE PREVIOUS PARAGRAPH. IF A SALE OR TRANSFER OF THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN IS MADE
IN CONTRAVENTION OF THE PRECEDING PARAGRAPH, THE ISSUER OF THIS SECURITY MAY REQUIRE SUCH TRANSFEREE TO TRANSFER THIS SECURITY OR THE
APPLICABLE BENEFICIAL INTEREST HEREIN TO A PERSON THAT WOULD HAVE BEEN A PERMITTED TRANSFEREE OF SUCH TRANSFEREE’S TRANSFEROR.
IF THE OBLIGATION TO TRANSFER DESCRIBED IN THE PRECEDING SENTENCE IS NOT MET, THE ISSUER HEREOF IS IRREVOCABLY AUTHORIZED, WITHOUT ANY
OBLIGATION, TO TRANSFER THIS SECURITY OR THE APPLICABLE BENEFICIAL INTEREST HEREIN IN A MANNER CONSISTENT WITH THE RESTRICTIONS SET FORTH
IN THIS PARAGRAPH AND, IF THIS SECURITY OR SUCH BENEFICIAL INTEREST HEREIN IS SOLD, THE ISSUER HEREOF SHALL DISTRIBUTE THE NET PROCEEDS
OF SUCH SALE TO THE ENTITLED PERSON.

 

THIS
SECURITY IS NOT A DEPOSIT, BANK ACCOUNT OR OBLIGATION OF ANY BANK. THIS SECURITY IS NOT INSURED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION
OR ANY OTHER AGENCY, AND IS SUBJECT TO INVESTMENT RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL.”

 

6.
Miscellaneous. 

 

a.
Successors and Assigns. Except as otherwise provided in this Agreement, the terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing in this Agreement is intended to
confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, or obligations under
or by reason of this Agreement, except as expressly provided herein.

 

    	 

     

    

 

b.
Governing Law. This Agreement shall be governed by and construed under the laws of the State of Delaware without regard to conflict
of laws principles.

 

c.
Counterparts; Signatures. This Agreement is intended to be executed in two or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. Counterpart signature pages to this Agreement may
be delivered by Docusign, .pdf and/or electronic transmission.

 

d.
Notices. Unless otherwise provided, any notice, request, or other communication shall in writing and shall be given by personal
delivery, national overnight courier, by certified or registered United States mail, postage prepaid to the addresses or to the email
address set forth on the signature page hereof. In case of service by mail, notices shall be deemed complete at the expiration of the
second business day after mailing.

 

e.
Amendments and Waivers. Except as otherwise provided herein, any term of this Agreement may be amended and the observance of any
term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with
the written consent of the Company and the holders of at least 51% of the outstanding principal amount due under the Notes. Any amendment
or waiver effected in accordance with this paragraph shall be binding upon each holder of any securities purchased under this Agreement
at the time outstanding, each future holder of all such securities, and the Company.

 

f.
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall
be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so excluded and shall
be enforceable in accordance with its terms.

 

g.
Exculpation Among Investors. Each Investor acknowledges that such Investor is not relying upon any person, firm or corporation,
other than the Company and its officers and directors, in making its investment or decision to invest in the Company. Each Investor agrees
that no other Investor, nor the respective controlling persons, officers, directors, partners, agents or employees of any other Investor
shall be liable for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with sale, issuance
and enforcement of the Notes.

 

h.
Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement among the parties and no
party shall be liable or bound to any other party in any manner by any warranty, representation, or covenant except as specifically set
forth herein.

 

    	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Note Purchase Agreement as of the date first above written.

 

	bioAffinity
    Technologies, Inc.	 
	 	 	 
	By:	                            	 
	 	 	 
	Maria
    Zannes	 
	Chief
    Executive Officer	 
	Address:
    22211 W Interstate 10	 
	Suite
    1206	 
	San
    Antonio, Texas 78257	 
	Email
    Address: mz@bioaffinitytech.com	 

 

    	 

     

    

 

The
undersigned hereby acknowledges and agrees to become party to and to succeed to all of the rights and obligations of an “Investor”
under the Note Purchase Agreement. By execution hereof, the undersigned hereby authorizes the Company to append this signature page as
a counterpart signature page to the Note Purchase Agreement.

 

PRINCIPAL
BALANCE: _______________________________________

 

	INVESTOR:	 	 
	 	 	 
	Individual:	 	Address:
	 	 	 
	 	 	 
	Print
    name:	 	Email:
	 	 	 
	Entity:	 	 
	 	 	 
	 	 	 
	(name
    of entity)	 	 
	 	 	 	 
	By:	 	 	 
	Name:	 	 	 
	Title:	 	 	 

 

Investor
Signature Page to Note Purchase Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]